Intuitive Surgical, Inc. $ISRG Shares Sold by E. Ohman J or Asset Management AB

E. Ohman J or Asset Management AB cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 16.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,680 shares of the medical equipment provider’s stock after selling 4,626 shares during the period. E. Ohman J or Asset Management AB’s holdings in Intuitive Surgical were worth $13,411,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. SteelPeak Wealth LLC boosted its stake in Intuitive Surgical by 28.7% during the third quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock worth $18,781,000 after buying an additional 9,364 shares during the period. Atlantic Union Bankshares Corp raised its stake in shares of Intuitive Surgical by 19.3% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider’s stock valued at $10,179,000 after acquiring an additional 3,676 shares during the period. World Investment Advisors lifted its holdings in shares of Intuitive Surgical by 238.3% in the 3rd quarter. World Investment Advisors now owns 5,399 shares of the medical equipment provider’s stock worth $2,415,000 after acquiring an additional 3,803 shares during the last quarter. Valley Wealth Managers Inc. lifted its holdings in shares of Intuitive Surgical by 52.7% in the 3rd quarter. Valley Wealth Managers Inc. now owns 4,084 shares of the medical equipment provider’s stock worth $1,826,000 after acquiring an additional 1,409 shares during the last quarter. Finally, AGF Management Ltd. boosted its position in shares of Intuitive Surgical by 0.6% during the 3rd quarter. AGF Management Ltd. now owns 464,179 shares of the medical equipment provider’s stock worth $207,595,000 after purchasing an additional 2,575 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $478.04 on Tuesday. The stock’s 50-day moving average is $500.94 and its two-hundred day moving average is $513.62. The firm has a market cap of $169.77 billion, a price-to-earnings ratio of 60.59, a PEG ratio of 3.69 and a beta of 1.66. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same period last year, the firm posted $2.21 earnings per share. The company’s revenue for the quarter was up 18.8% compared to the same quarter last year. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity

In related news, EVP Myriam Curet sold 105 shares of the firm’s stock in a transaction dated Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Fredrik Widman sold 133 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the sale, the vice president directly owned 660 shares in the company, valued at $326,673.60. This trade represents a 16.77% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 32,943 shares of company stock worth $17,279,568 over the last quarter. Insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on ISRG. HSBC boosted their price objective on Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a report on Monday, January 26th. Argus dropped their target price on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Truist Financial boosted their price target on shares of Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research note on Thursday, December 18th. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Finally, TD Cowen upgraded shares of Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $614.95.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.